{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:02:47Z","timestamp":1792105367226,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["Clinical Academic Fellowship (CAF_17_06)"],"award-info":[{"award-number":["Clinical Academic Fellowship (CAF_17_06)"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People who die from cancer (\u2018cancer decedents\u2019) may latterly experience unpleasant and distressing symptoms. Prescribing medication for pain and symptom control is essential for good-quality palliative care; however, such provision is variable, difficult to quantify and poorly characterised in current literature. This study aims to characterise trends in prescribing analgesia, non-analgesic palliative care medication and non-palliative medications, to cancer decedents, in their last year of life, and to assess any associations with demographic or clinical factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This descriptive study, analysed all 181,247 prescriptions issued to a study population of 2443 cancer decedents in Tayside, Scotland (2013\u20132015), in the last year of life, linking prescribing data to demographic, and cancer registry datasets using the unique patient-identifying Community Health Index (CHI) number. Anonymised <jats:bold>l<\/jats:bold>inked data were analysed in Safe Haven using chi-squared test for trend, binary logistic regression and Poisson regression in SPSSv25.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In their last year of life, three in four cancer decedents were prescribed strong opioids. Two-thirds of those prescribed opioids were also prescribed laxatives and\/or anti-emetics. Only four in ten cancer decedents were prescribed all medications in the \u2018Just in Case\u2019 medication categories and only one in ten was prescribed breakthrough analgesia in the last year of life. The number of prescriptions for analgesia and palliative care drugs increased in the last 12\u2009weeks of life. The number of prescriptions for non-palliative care medications, including anti-hypertensives, statins and bone protection, decreased over the last year, but was still substantial. Cancer decedents who were female, younger, or had lung cancer were more likely to be prescribed strong opioids; however, male cancer decedents had higher odds of being prescribed breakthrough analgesia. Cancer decedents who had late diagnoses had lower odds of being prescribed strong opioids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A substantial proportion of cancer decedents were not prescribed strong opioids, breakthrough medication, or medication to alleviate common palliative care symptoms (including \u2018Just in Case\u2019 medication). Many patients continued to be prescribed non-palliative care medications in their last days and weeks of life. Age, gender, cancer type and timing of diagnosis affected patients\u2019 odds of being prescribed analgesic and non-analgesic palliative care medication.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12904-022-00996-3","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:04:38Z","timestamp":1657245878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Community prescribing trends and prevalence in the last year of life, for people who die from cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Sarah E. E.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deans","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"996_CR1","unstructured":"Cancer Research UK C. Cancer Statistics for the UK. https:\/\/www.cancerresearchuk.org\/healthprofessional\/cancer-statistics-for-the-uk2020. Accessed 1 Nov 2021."},{"key":"996_CR2","volume-title":"GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No 11","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No 11. Lyon: International Agency for Research on Cancer; 2013. http:\/\/globocan.iarc.fr"},{"key":"996_CR3","unstructured":"Information Services Division (ISD) Report. Cancer Mortality in Scotland. A National Statistics Publication for Scotland. 2015. Published 25 Oct 2016. https:\/\/www.isdscotland.org\/Health-Topics\/Cancer\/Publications\/2016-10-25\/2016-10-25-Cancer-Mortality-Summary.pdf?733584166. Accessed 30 Oct 2021."},{"issue":"2","key":"996_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0269216317713428","volume":"32","author":"L Henson","year":"2018","unstructured":"Henson L, Higginson I, Gao W. What factors influence emergency department visits by patients with cancer at the end of life? Analysis of a 124,030 patient study population. J Palliat Med. 2018;32(2):426\u201338.","journal-title":"J Palliat Med"},{"issue":"5","key":"996_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jpainsymman.2006.05.023","volume":"32","author":"A Doorenbos","year":"2006","unstructured":"Doorenbos A, Given C, Given B, Verbitsky N. Symptom experience in the last year of life among individuals with cancer. J Pain Symptom Manag. 2006;32(5):403\u201312.","journal-title":"J Pain Symptom Manag"},{"key":"996_CR6","unstructured":"Dixon J, King D, Matosevic T, Clark M, Knapp M. Equality in the Provision of Palliative Care in the UK: Review of Evidence. Marie Curie. 2015. https:\/\/www.mariecurie.org.uk\/globalassets\/media\/documents\/policy\/campaigns\/equity-palliative-careuk-report-full-lse.pdf. Accessed 1 Nov 2021."},{"key":"996_CR7","unstructured":"World Health Organization. Declaration of Astana: Global Conference on Primary Health Care: Astana, Kazakhstan, 25 and 26 October 2018. World Health Organization; 2019. https:\/\/apps.who.int\/iris\/handle\/10665\/328123. License: CC BY-NC-SA 3.0 IGO. Document number: WHO\/HIS\/SDS\/2018.61."},{"key":"996_CR8","unstructured":"Public Health Scotland. Percentage of End of Life Spent at Home or in a Community Setting. Financial years ending 31 March 2011 to 2020. Published October 2020. https:\/\/publichealthscotland.scot\/media\/4284\/2020-10-20_end-of-life-report.pdf. Accessed 20 Oct 2021."},{"key":"996_CR9","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.3399\/bjgp16X686113","volume":"66","author":"S Mitchell","year":"2016","unstructured":"Mitchell S, Loew J, Millington-Sanders C, Dale J. Providing end-of-life care in general practice: findings of a national GP questionnaire survey. Br J Gen Pract. 2016;66:e647\u201353.","journal-title":"Br J Gen Pract"},{"issue":"3","key":"996_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jpainsymman.2014.07.007","volume":"49","author":"MO Delgado-Guay","year":"2015","unstructured":"Delgado-Guay MO, Kim YJ, Shin SH, Chisolm G, Williams J, Allo J, et al. Avoidable and unavoidable visits to the emergency department among patients with advanced cancer receiving outpatient palliative care. J Pain Symptom Manag. 2015;49(3):497\u2013504.","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"996_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1503\/cmaj.091187","volume":"182","author":"L Barbera","year":"2010","unstructured":"Barbera L, Taylor C, Dudgeon D. Why do patients with cancer visit the emergency department near the end of life? CMAJ. 2010;182(6):563\u20138.","journal-title":"CMAJ."},{"issue":"7","key":"996_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1049909115581819","volume":"33","author":"S Alsirafy","year":"2015","unstructured":"Alsirafy S, Raheem A, Al-Zahrani A, al. e. Emergency department visits at the end of life of patients with terminal Cancer: pattern, causes, and Avoidability. Am J Hosp Palliat Care. 2015;33(7):658\u201362.","journal-title":"Am J Hosp Palliat Care"},{"issue":"5","key":"996_CR13","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s00520-015-3034-9","volume":"24","author":"MO Delgado-Guay","year":"2015","unstructured":"Delgado-Guay MO, Rodriguez-Nunez A, Shin SH, Chisolm G, Willians J, Frisbee-Hume S, et al. Characteristics and outcomes of patients with advanced cancer evaluated by a palliative care team at an emergency center. A retrospective study. Support Care Cancer. 2015;24(5):2287\u201395.","journal-title":"Support Care Cancer"},{"issue":"522","key":"996_CR14","first-page":"6","volume":"56","author":"A Worth","year":"2006","unstructured":"Worth A, Boyd K, Kendall M, Heaney D, Macleod U, Cormie P, et al. Out-of-hours palliative care: a qualitative study of cancer patients, carers and professionals. Br J Gen Pract. 2006;56(522):6\u201313.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"996_CR15","doi-asserted-by":"publisher","first-page":"e002515","DOI":"10.1136\/bmjopen-2012-002515","volume":"3","author":"M Hjermstad","year":"2013","unstructured":"Hjermstad M, Kolflaath J, Lokken A, Hanssen SB, Normann AP, Aass N. Are emergency admissions in palliative cancer care always necessary? Results from a descriptive study. BMJ Open. 2013;3(5):e002515.","journal-title":"BMJ Open"},{"issue":"4","key":"996_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/sajc.sajc_128_17","volume":"6","author":"A Joshi","year":"2017","unstructured":"Joshi A, Patil VM, Noronha V, Ramaswamy A, Gupta S, Bhattacharjee A, et al. EMERALD: emergency visit audit of patients treated under medical oncology in a tertiary cancer center: logical steps to decrease the burden. South Asian J Cancer. 2017;6(4):186\u20139.","journal-title":"South Asian J Cancer"},{"issue":"1","key":"996_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12904-018-0302-8","volume":"17","author":"YH Kao","year":"2018","unstructured":"Kao YH, Liu YT, Koo M, Chiang JK. Factors associated with emergency services use in Taiwanese advanced cancer patients receiving palliative home care services during out-of-hours periods: a retrospective medical record study. BMC Palliat Care. 2018;17(1):46.","journal-title":"BMC Palliat Care"},{"issue":"5","key":"996_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1062860618757343","volume":"33","author":"C Hay","year":"2018","unstructured":"Hay C, Kelley J, Edwards R, Pombier K, Comerci J. Super-utilization of health care resources among gynecologic oncology patients. Am J Med Qual. 2018;33(5):509\u201313.","journal-title":"Am J Med Qual"},{"issue":"5","key":"996_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0269216316663508","volume":"31","author":"R Sutradhar","year":"2017","unstructured":"Sutradhar R, Barbera L, Seow HY. Palliative homecare is associated with reduced high- and low-acuity emergency department visits at the end of life: a population-based study population study of cancer decedents. Palliat Med. 2017;31(5):448\u201355.","journal-title":"Palliat Med"},{"issue":"16","key":"996_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2169\/internalmedicine.7629-16","volume":"56","author":"P Tang","year":"2017","unstructured":"Tang P, Chang H, Cheng C, Chen H, Kuo S, Hsiao K, et al. An analysis of emergency department visits and the survival rate for colorectal Cancer patients: a Nationwide population-based study. Intern Med. 2017;56(16):2125\u201332.","journal-title":"Intern Med"},{"key":"996_CR21","unstructured":"Wood C, Salter J. A time and a place: what people want at the end of life, Sue Ryder\/Demos. 2013. https:\/\/www.scribd.com\/document\/152645404\/A-time-and-a-place-What-people-want-attheend-of-life. Accessed 2 Nov 2021."},{"issue":"15","key":"996_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/archinternmed.2012.2364","volume":"172","author":"B Zhang","year":"2012","unstructured":"Zhang B, Nilsson ME, Prigerson HG. Factors important to patients\u2019 quality of life at the end of life. Arch Intern Med. 2012;172(15):1133\u201342.","journal-title":"Arch Intern Med"},{"issue":"7228","key":"996_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/bmj.320.7228.129","volume":"320","author":"R Smith","year":"2000","unstructured":"Smith R. A good death. An important aim for health services and for us all. BMJ. 2000;320(7228):129\u201330.","journal-title":"BMJ"},{"issue":"4","key":"996_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hed.25534","volume":"41","author":"M Kligerman","year":"2019","unstructured":"Kligerman M, Sethi R, Kozin E, Gray S, Shrime M. Morbidity and mortality among patients with head and neck cancer in the emergency department: a national perspective. Head Neck. 2019;41(4):1007\u201315.","journal-title":"Head Neck"},{"issue":"5","key":"996_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/fampra\/cmy124","volume":"36","author":"D Ermers","year":"2019","unstructured":"Ermers D, van Bussel K, Perry M, Engels Y, Schers H. Advance care planning for patients with cancer in the palliative phase in Dutch general practices. Fam Pract. 2019;36(5):587\u201393.","journal-title":"Fam Pract"},{"issue":"8","key":"996_CR26","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/annonc\/mdr602","volume":"23","author":"B Gomes","year":"2012","unstructured":"Gomes B, Higginson I, Calanzani N, Cohen J, Deliens L, Daveson B, et al. Preferences for place of death if faced with advanced cancer: a popu- lation survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain. Ann Oncol. 2012;23(8):2006\u201315.","journal-title":"Ann Oncol"},{"issue":"3","key":"996_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0269216309360489","volume":"24","author":"I Higginson","year":"2010","unstructured":"Higginson I, Hall S, Koffman J, Riley J, Gomes B. Time to get it right: are preferences for place of death more stable than we think? Palliat Med. 2010;24(3):352\u20133.","journal-title":"Palliat Med"},{"issue":"2","key":"996_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpainsymman.2015.10.008","volume":"51","author":"H Seow","year":"2016","unstructured":"Seow H, Barbera L, Pataky R, Beverley L, O\u2019Leary E, Fassbender K, et al. Does increasing home care nursing reduce emergency department visits at the end of life? A population-based study population study of Cancer decedents. J Pain Symptom Manag. 2016;51(2):204\u201312.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"996_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5152\/jaem.2015.58672","volume":"14","author":"N Basol","year":"2015","unstructured":"Basol N, Celtek N, Alatli T, Koc I. Evaluation of terminal-stage Cancer patients needing palliative Care in the Emergency Department. Acad Emerg Med. 2015;14(1):12\u20135.","journal-title":"Acad Emerg Med"},{"issue":"5","key":"996_CR30","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1097\/NCC.0000000000000098","volume":"37","author":"S Chellappan","year":"2014","unstructured":"Chellappan S, Ezhilarasu P, Gnanadurai A, George R, Christopher S. Can symptom relief be provided in the home to palliative care cancer patients by the primary caregivers? An Indian study. Cancer Nurs. 2014;37(5):E40\u20137.","journal-title":"Cancer Nurs"},{"key":"996_CR31","unstructured":"National Institute for Health and Care Excellence (NICE). Care of dying adults in the last days of life (NG31). Available at: https:\/\/www.nice.org.uk\/guidance\/ng31 (accessed November, 2021). 2015."},{"key":"996_CR32","volume-title":"British national formulary","author":"Joint Formulary Committee","year":"2016","unstructured":"Joint Formulary Committee. British national formulary. 71st ed. London: BMJ Group and Pharmaceutical Press; 2016.","edition":"71"},{"key":"996_CR33","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett M, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58\u201368.","journal-title":"Lancet Oncol"},{"key":"996_CR34","unstructured":"World Health Organisation. Cancer Pain Relief 1986."},{"key":"996_CR35","doi-asserted-by":"publisher","unstructured":"Kaasa S. Is Cancer Pain Control Improved by a Simple WHO Pain Analgesic Ladder Approach Combined With Tumor-Directed Treatment? J Clin Oncol. 2016;34(5):399-400. https:\/\/doi.org\/10.1200\/JCO.2015.64.7537.","DOI":"10.1200\/JCO.2015.64.7537"},{"key":"996_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1200\/JCO.2015.61.0733","volume":"34","author":"E Bandieri","year":"2016","unstructured":"Bandieri E, Romero M, Ripamonti C. A randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol. 2016;34:436\u201342.","journal-title":"J Clin Oncol"},{"issue":"1","key":"996_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/ejhpharm-2011-000017","volume":"19","author":"N Cherny","year":"2012","unstructured":"Cherny N. How well are we doing in treating cancer pain in Europe: key findings of the European pain in Cancer report. Eur J Hosp Pharm. 2012;19(1):31\u20133.","journal-title":"Eur J Hosp Pharm"},{"issue":"35","key":"996_CR38","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1200\/JCO.2012.42.0919","volume":"30","author":"I Higginson","year":"2012","unstructured":"Higginson I, Gao W. Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United Kingdom study population study. J Clin Oncol. 2012;30(35):4373\u20139.","journal-title":"J Clin Oncol"},{"key":"996_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/sim.4780080704","volume":"8","author":"FY Hsieh","year":"1989","unstructured":"Hsieh FY. Sample size tables for logistic regression. Statist Med. 1989;8:795\u2013802.","journal-title":"Statist Med"},{"issue":"4","key":"996_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5935\/1806-0013.20160081","volume":"17","author":"IF Cella","year":"2016","unstructured":"Cella IF, Trindade LCT, Sanvido LV, Skare TL. Prevalence of opiophobia in cancer pain treatment. Revista Dor. 2016;17(4):245\u20137.","journal-title":"Revista Dor"},{"issue":"1","key":"996_CR41","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1200\/JOP.18.00254","volume":"15","author":"L Robin","year":"2019","unstructured":"Robin L, Whitney JFB, Tancredi DJ, Romano PS, Bold RJ, Wun T, et al. Unplanned hospitalization among individuals with Cancer in the year after diagnosis. J Oncol Pract. 2019;15(1):e20\u2013e9.","journal-title":"J Oncol Pract"},{"key":"996_CR42","unstructured":"Information Services Division (ISD) Report. Percentage of End of Life Spent at Home or in a Community Setting. 1-25. Published 29 May 2018. https:\/\/www.isdscotland.org\/Health-Topics\/Health-and-Social-Community-Care\/Publications\/2018-05-29\/2018-05-29-End-of-Life-Report.pdf?17946959. Accessed 1 Oct 2021."}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-022-00996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-022-00996-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-022-00996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:05:48Z","timestamp":1657245948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-022-00996-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1186\/s12904-022-00996-3","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"18 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Tayside medical Science Centre (TASC) Tayside Research Ethics Committee (REC) (reference 14\/ES\/0015). All methods were performed in accordance with the relevant guidelines and regulations. No human participants were used in this study. Informed consent from legal guardians of patients included in this study was obtained; in Scotland, for posthumous data, the legal guardian for data is the data controller and Caldicott Guardian. The Caldicott Guardian approval reference for this study is Caldicott\/CSAppSM1952.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PTD provides statistical support to the Scottish Medicines Consortium. The authors have declared no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}